Zuclomifene: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''Zuclomifene''' (also known as '''Zuclomiphene''') is a [[nonsteroidal]] [[selective estrogen receptor modulator]] (SERM) that is structurally related to [[clomifene]]. It is one of the two [[isomers]] of clomifene, the other being [[enclomifene]].
== Zuclomifene ==


==Chemistry==
[[File:Zuclomifene.png|thumb|right|Chemical structure of Zuclomifene]]
Zuclomifene is a [[triazine]] derivative and is classified as a SERM due to its ability to compete with [[estrogen]] for binding sites in target tissues. It has a molecular formula of C26H28ClNO and a molecular weight of 405.959 g/mol.


==Pharmacology==
'''Zuclomifene''' is a nonsteroidal [[selective estrogen receptor modulator]] (SERM) that is used in the treatment of [[infertility]] in women. It is one of the two geometric isomers of [[clomifene]], the other being [[enclomifene]]. Zuclomifene is the more active isomer and is responsible for the majority of the pharmacological effects of clomifene.
Zuclomifene acts as an [[antagonist]] at estrogen receptors in the [[hypothalamus]] and [[pituitary gland]], inhibiting negative feedback of estrogen on [[gonadotropin]] release, leading to an increase in the production of [[gonadotropins]], [[follicle-stimulating hormone]] (FSH) and [[luteinizing hormone]] (LH).


==Clinical Use==
== Mechanism of Action ==
Zuclomifene is used in the treatment of [[female infertility]] due to [[anovulation]] (e.g., due to [[polycystic ovary syndrome]]). It is also used in [[male infertility]] as it can increase [[sperm]] production.


==Side Effects==
Zuclomifene works by binding to [[estrogen receptors]] in the [[hypothalamus]], which leads to an increase in the release of [[gonadotropin-releasing hormone]] (GnRH). This, in turn, stimulates the [[pituitary gland]] to release [[follicle-stimulating hormone]] (FSH) and [[luteinizing hormone]] (LH), which promote [[ovulation]] in women who are anovulatory or oligo-ovulatory.
Common side effects of zuclomifene include [[hot flashes]], [[abdominal discomfort]], and [[visual disturbances]]. More serious side effects can include [[ovarian hyperstimulation syndrome]] and multiple pregnancies.
 
== Clinical Use ==
 
Zuclomifene is primarily used in the treatment of [[female infertility]] due to [[anovulation]], such as in [[polycystic ovary syndrome]] (PCOS). It is administered orally and is typically given in a cycle of 5 days, starting on the fifth day of the menstrual cycle.
 
== Side Effects ==
 
Common side effects of zuclomifene include [[hot flashes]], [[abdominal discomfort]], and [[breast tenderness]]. In some cases, it may cause [[ovarian hyperstimulation syndrome]] (OHSS), which can be a serious condition.
 
== Pharmacokinetics ==
 
Zuclomifene is well absorbed from the gastrointestinal tract and has a long half-life, which allows for once-daily dosing. It is metabolized in the [[liver]] and excreted primarily in the [[feces]].
 
== Related Compounds ==
 
Zuclomifene is closely related to [[enclomifene]], the other isomer of clomifene. While both isomers have similar effects, zuclomifene is considered to be the more potent of the two.
 
== Related Pages ==


==See Also==
* [[Clomifene]]
* [[Clomifene]]
* [[Enclomifene]]
* [[Selective estrogen receptor modulator]]
* [[Selective estrogen receptor modulator]]
* [[Female infertility]]
* [[Infertility]]
* [[Male infertility]]
* [[Ovulation induction]]


[[Category:Selective estrogen receptor modulators]]
[[Category:Selective estrogen receptor modulators]]
[[Category:Infertility treatments]]
[[Category:Fertility medicine]]
[[Category:Triazines]]
{{Pharm-stub}}
{{Medicine-stub}}

Latest revision as of 03:55, 13 February 2025

Zuclomifene[edit]

File:Zuclomifene.png
Chemical structure of Zuclomifene

Zuclomifene is a nonsteroidal selective estrogen receptor modulator (SERM) that is used in the treatment of infertility in women. It is one of the two geometric isomers of clomifene, the other being enclomifene. Zuclomifene is the more active isomer and is responsible for the majority of the pharmacological effects of clomifene.

Mechanism of Action[edit]

Zuclomifene works by binding to estrogen receptors in the hypothalamus, which leads to an increase in the release of gonadotropin-releasing hormone (GnRH). This, in turn, stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which promote ovulation in women who are anovulatory or oligo-ovulatory.

Clinical Use[edit]

Zuclomifene is primarily used in the treatment of female infertility due to anovulation, such as in polycystic ovary syndrome (PCOS). It is administered orally and is typically given in a cycle of 5 days, starting on the fifth day of the menstrual cycle.

Side Effects[edit]

Common side effects of zuclomifene include hot flashes, abdominal discomfort, and breast tenderness. In some cases, it may cause ovarian hyperstimulation syndrome (OHSS), which can be a serious condition.

Pharmacokinetics[edit]

Zuclomifene is well absorbed from the gastrointestinal tract and has a long half-life, which allows for once-daily dosing. It is metabolized in the liver and excreted primarily in the feces.

Related Compounds[edit]

Zuclomifene is closely related to enclomifene, the other isomer of clomifene. While both isomers have similar effects, zuclomifene is considered to be the more potent of the two.

Related Pages[edit]